Patents by Inventor Junyan A. Ji

Junyan A. Ji has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240209111
    Abstract: The disclosure provides pharmaceutical compositions comprising mosunetuzumab and methods of using the same.
    Type: Application
    Filed: March 8, 2024
    Publication date: June 27, 2024
    Inventors: Junyan A. JI, Jacqueline Yvonne Tyler
  • Patent number: 11958906
    Abstract: The disclosure provides pharmaceutical compositions comprising mosunetuzumab and methods of using the same.
    Type: Grant
    Filed: April 13, 2023
    Date of Patent: April 16, 2024
    Assignee: Genentech, Inc.
    Inventors: Junyan A. Ji, Jacqueline Yvonne Tyler
  • Publication number: 20230331861
    Abstract: The disclosure provides pharmaceutical compositions comprising mosunetuzumab and methods of using the same.
    Type: Application
    Filed: April 13, 2023
    Publication date: October 19, 2023
    Inventors: Junyan A. JI, Jacqueline Yvonne TYLER
  • Publication number: 20130171162
    Abstract: The invention relates to pharmaceutical formulations comprising a protein and free methionine in combination with one or more compounds capable of preventing the oxidation of aromatic amino acid residues within a protein. More specifically, the invention relates to stabilized, pharmaceutically effective preparations of oxidation-sensitive therapeutic agents. The invention further relates to a method of inhibiting the oxidation of such therapeutic agents.
    Type: Application
    Filed: June 28, 2012
    Publication date: July 4, 2013
    Inventors: JUNYAN A. JI, Yuchang John Wang, Boyan Zhang
  • Publication number: 20100068210
    Abstract: The invention relates to pharmaceutical formulations comprising a protein and free methionine in combination with one or more compounds capable of preventing the oxidation of aromatic amino acid residues within a protein. More specifically, the invention relates to stabilized, pharmaceutically effective preparations of oxidation-sensitive therapeutic agents. The invention further relates to a method of inhibiting the oxidation of such therapeutic agents.
    Type: Application
    Filed: September 9, 2009
    Publication date: March 18, 2010
    Inventors: Junyan A. Ji, Yuchang John Wang, Boyan Zhang